| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Graves Paul W | Director | C/O CHARLES RIVER LABORATORIES, 251 BALLARDVALE STREET, WILMINGTON | /s/ Paul Graves | 2025-06-04 | 0001559551 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | CRL | Common Stock | Award | $128K | +946 | $135.04 | 946 | Jun 2, 2025 | Direct | F1 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | CRL | Stock Options (Right to Buy) | Award | $281K | +2.08K | $135.04 | 2.08K | Jun 2, 2025 | Common Stock | 2.08K | $135.04 | Direct | F2 |
| Id | Content |
|---|---|
| F1 | The unvested restricted stock units vest upon the earlier of 6/2/2026 or the business day prior to the Company's next annual meeting of shareholders. |
| F2 | The stock options become exercisable upon the earlier of 6/2/2026 or the business day prior to the Company's next annual meeting of shareholders. |